Trinity Biotech ADR buy StockNews.com
Start price
12.08.23
/
50%
€0.69
Target price
12.08.24
-
Performance (%)
-38.55%
Price
22.02.24
€0.41
Summary
This prediction is currently active. The BUY prediction by StockNews_com for Trinity Biotech ADR is performing very badly with a performance of -38.55%. This prediction currently runs until 12.08.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Trinity Biotech ADR | - | - |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat